Popular Trials
Myopia Control
DG1 Spectacle Lens for Near-sightedness
Recruiting0 awards1 criteria
Medina, Minnesota
This trial aims to test the safety and effectiveness of a special DG1 lens for controlling myopia progression in children. They will compare this DG1 lens with regular single-vision spectacles to see if
Behavioral Intervention
Symptom Monitoring for Breast Cancer
Recruiting1 award5 criteria
Rochester, Minnesota
This trial aims to help breast cancer patients who are at risk of not taking their hormone therapy medication regularly. Patients will report their symptoms monthly, and pharmacists specializing in cancer will provide recommendations to help manage
Antibody-Drug Conjugate
Enfortumab Vedotin + Pembrolizumab for Bladder Cancer
Recruiting3 awardsPhase 4
Rochester, Minnesota
"This trial is testing the effects of standard treatment with enfortumab vedotin and pembrolizumab followed by surgery to remove part or all of the bladder or ureter in patients with
Popular Filters
Trials With No Placebo
Ultrasound Imaging
Ultrasound for Portal Hypertension
Recruiting1 award
Rochester, Minnesota
"This trial aims to test if a noninvasive ultrasound technique called subharmonic imaging and SHAPE can accurately identify portal hypertension (PH), which is high blood pressure in the vein leading to the liver
Behavioural Intervention
Transcranial Magnetic Stimulation for Stimulant Use Disorder
Recruiting1 awardPhase 1
Minneapolis, Minnesota
This trial will involve 50 adults with stimulant use disorder who have been abstinent for at least 2 weeks. It will also include up to 10 healthy individuals for comparison. The study will
Behavioural Intervention
Breathing Practice for Multiple Sclerosis and Cancer
Recruiting1 award1 criteria
Rochester, Minnesota
This trial aims to see if breathing exercises can improve brain and mental health in patients with multiple sclerosis and cancer, as well as their caregivers. By studying how breathing affects the brain and mental health, researchers
Monoclonal Antibodies
Elotuzumab + Daratumumab + Iberdomide + Dexamethasone for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
Rochester, Minnesota
This trial is testing the safety and effectiveness of a combination of iberdomide, daratumumab, elotuzumab, and dexamethasone in treating patients with relapsed
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.